Australia's largest stock trading and investment forum Australia's #1 stock forum

Nico.lab Pre IPO, page-611

First 611 Last

Share
Profile

Follow
sle

11,004 Posts.

353

22/06/23

07:54

Post #: 68410266
Share

Originally posted by sle: ↑

Interesting no talk on Nico from holders. Apparently share holders to be updated in relation to the latest institutional raise when news comes. The Victorian deal is now on their website. Still would probably prefer a US listing in the latter part of next year.

I'm also interested in this:

Nicolab is finalising a Memorandum of Understanding with a pre-eminent organisation in the digital health and AI-powered clinical
decision space, to leverage their respective expertise and resources to deliver high-quality telehealth services for stroke care to
patients in Australia, predominantly focussed on regional, remote and Indigenous communities.

Exciting news is this:

The final study results were outstanding, showing that our algorithm is highly accurate.
These results form the basis of our FDA submission. We are on track to submit our Perfusion algorithm to the FDA by the end of the May
2023, in accordance with previously communicated timelines.

Expand

Looks like Queensland Health are happy with Nico with the latest twitters from Nico. Onwards and upwards. Wonder how the raise went?
If successful makes those shares for sale on Primarymarkets appear very cheap!
3 Upvote

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

First 611 Last

SPONSORED BY